Bayer – Page 2 – Talk Bio

Bayer’s Q3 Earnings Plummet 37%, CEO Urges Patience Amid Performance-Boosting Strategy

9 months ago talkbio0Tagged Avian crop, Bayer, Bill Anderson, CEO, decline, earnings, generics, Kerendia, Nubeqa, performance-boosting strategy

Bayer, Q3 earnings, decline, CEO Bill Anderson, performance-boosting strategy, pharmaceuticals, crop science, generics, Xarelto, Nubeqa, Kerendia.

Bayer and Dewpoint Therapeutics Collaborate on Dilated Cardiomyopathy Program with $424 Million Deal

9 months ago talkbio0Tagged Bayer, Cardiomyopathy, Dilated, Dewpoint Therapeutics, Dosage Forms

Bayer, Dewpoint Therapeutics, Dilated Cardiomyopathy, DCM, Pharmaceutical Deal

Pharmaceutical Giants J&J, Bayer, and Pfizer Announce Layoffs Affecting Nearly 500 Employees

10 months ago talkbio0Tagged Bayer, Biotech Layoffs, Drug Industry, Johnson & Johnson, layoffs, Pfizer

Layoffs, Pharmaceutical Industry, Johnson & Johnson, Bayer, Pfizer, Biotech Layoffs, Workforce Reduction

Pharmaceutical Giants J&J and Bayer Announce Layoffs of Nearly 300 Employees in New Jersey

10 months ago talkbio0Tagged Bayer, Drug Industry, Johnson and Johnson, New Jersey

Johnson & Johnson, Bayer, layoffs, New Jersey, pharmaceutical industry, job cuts

Big Pharma’s Layoff Wave Continues in New Jersey: J&J and Bayer Announce Significant Job Cuts

10 months ago talkbio0Tagged Bayer, Big Pharma layoffs, Drug Industry, Johnson & Johnson, New Jersey, restructuring

Big Pharma layoffs, New Jersey, Johnson & Johnson, Bayer, pharmaceutical industry restructuring

Biopharma Leaders Navigate AI ‘Hype Cycle’: Bayer, Daiichi Sankyo, and argenx Share Insights on AI Implementation in Marketing

10 months ago talkbio0Tagged Argenx, Artificial Intelligence, Bayer, Biopharma, biopharma marketing, Daiichi, Implementation, Industry, Sankyo

AI in biopharma marketing, Bayer, Daiichi Sankyo, argenx, AI implementation, biopharma industry, AI hype cycle

Bayer Seeks to Broaden Nubeqa’s Use in Prostate Cancer with Chemotherapy-Free Treatment Option

10 months ago talkbio0Tagged Antiandrogen therapy, ARANOTE, Bayer, Chemotherapy-free, Clinical Trials, darolutamide, expansion, Labels (device), Malignant neoplasm of prostate, Metastatic to, mHSPC, Nubeqa

Nubeqa, Bayer, prostate cancer, chemotherapy-free, label expansion, ARANOTE trial, darolutamide, androgen deprivation therapy (ADT), metastatic hormone-sensitive prostate cancer (mHSPC)

Elinzanetant Demonstrates Sustained Efficacy Over One Year in Managing Menopausal Vasomotor Symptoms

11 months ago talkbio0Tagged Bayer, Elinzanetant, Menopause, Non-Hormonal, Sleep, Symptoms aspect, Vasomotor

Elinzanetant, Menopause, Vasomotor Symptoms, Sleep Disturbances, Non-Hormonal Treatment, Bayer

Roivant Sciences Acquires Experimental Pulmonary Hypertension Drug Mosliciguat from Bayer

11 months ago talkbio0Tagged Bayer, Lung Diseases, Interstitial, Mosliciguat, PH-ILD, Pulmonary Hypertension, Pulmovant, Roivant

Roivant Sciences, Pulmovant, Bayer, Mosliciguat, Pulmonary Hypertension, PH-ILD, Interstitial Lung Disease

WCLC24 Highlights: ArriVent’s Drug Aims to Address Tagrisso’s Limitations; Boehringer and Bayer Share Data on HER2-Mutated Lung Cancer

11 months ago talkbio0Tagged ArriVent, Bayer, Boehringer, EGFR-mutated, HER2-mutated lung cancer, Malignant neoplasm of lung, Tagrisso, WCLC24

WCLC24, ArriVent, Tagrisso, Boehringer, Bayer, HER2-mutated lung cancer, Lung cancer treatment, EGFR-mutated lung cancer